
Early stage carcinoma of the prostate is curable. Not every patient must be treated because there are significant differences in the biologic activity of the tumors. This causes a sharp difference between morbidity and mortality rate in prostatic cancer. Besides the clinical staging morphological malignancy grading is the trend factor for the treatment that has to be chosen because it has shown to be a reasonable and feasable prognostic indicator.
Male, Prostatectomy, Palliative Care, Prostatic Neoplasms, Adrenalectomy, Androgen Antagonists, Antineoplastic Agents, Estrogens, Prognosis, Pelvis, Cordotomy, Humans, Lymph Node Excision, Cyproterone, Neoplasm Metastasis, Hypophysectomy, Neoplasm Staging
Male, Prostatectomy, Palliative Care, Prostatic Neoplasms, Adrenalectomy, Androgen Antagonists, Antineoplastic Agents, Estrogens, Prognosis, Pelvis, Cordotomy, Humans, Lymph Node Excision, Cyproterone, Neoplasm Metastasis, Hypophysectomy, Neoplasm Staging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
